Newlywed Brooke Burke Charvet, co-host of Dancing with the Stars, puts the "it" in fit. After having four kids, the audacity to wear a sports bra and short shorts while running could only come from a woman who knows she's got it going on. Her new exercise DVD, Transform Your Body with Brooke Burke: Tone & Tighten, may help you shave an inch or two, but it takes more than a DVD to have a body as great as Brooke's. She tells Fitness her five-day-a-week workout regimen includes Pilates Plus and a couple visits to the gym where she goes for a short treadmill workout and full-body toning.
Brooke Burke Ties the Knot
Hottest Spot: Abs Even if they weren't so toned, her abs would still be her number one asset. While it's enviable that she lacks signs of carrying children, it's good to know she puts her kids, not her image, first. She reportedly schedules her workouts just as a doctor's appointment or sporting event for her kids, saying she never misses any of these things.
Guilty Pleasure: Spaghetti Bolognese Brooke wears her craving like a badge of honor. In the February 2012 issue of Ladies Home Journal she says, "If I really crave something, I'll eat it and then get back into the groove afterward. I don't feel like I've failed or fallen off the wagon. Eating healthy shouldn't be torture."
Favorite Sport: Butt Wiping Today Brooke tweeted her latest blog at? ModernMom.com with the title "The Greatest Butt Wiper." On second thought, it may be too cramped in the bathroom if the whole family decides to spectate. We probably don't need to know what makes her so good at it, seeing as hubby, David, is her only butt wiping competition.
SAN FRANCISCO ? Netflix regained 600,000 U.S. customers in the fourth quarter as the video subscription service began to recover from a revolt against a big price increase.
Figures released Wednesday show Netflix Inc. ended December with 24.4 million subscribers in the U.S. That was up from 23.8 million at the end of September.
The subscriber uptick is a positive sign for Netflix after several months of upheaval that battered its stock. Netflix lost 800,000 subscribers last summer after raising its U.S. prices by as much as 60 percent.
The fallout contributed to a 14 percent decrease in Netflix's fourth-quarter earnings.
Netflix made $40.7 million, or 73 cents per share, in the final three months of last year. That compares with income of $47.1 million, or 87 cents per share, a year earlier.
Investors had been bracing for a bigger drop-off. The company's performance easily exceeded the average earnings estimate of 54 cents per share among analysts surveyed by FactSet.
Fourth-quarter revenue climbed 47 percent from the previous year to $876 million ? $19 million above analyst projections.
Netflix's stock soared $11.63, or more than 12 percent, to $106.67 in extended trading. During the regular session, it increased $2.37, up 2.6 percent.
The stock still has a long way to go to return to its peak of nearly $305, which was reached in July, around the same time that Netflix announced the price increase that outraged customers.
But the fourth-quarter results should help bolster confidence in Netflix CEO Reed Hastings, who had been lambasted for miscalculating how subscribers would react to the higher prices.
Hastings had promised Netflix would work to lure back customers, and the fourth-quarter gains were even better than he had forecast.
Hiding behind a life-sized negative of yourself won't actually turn you invisible. But researchers at the University of Texas at Austin have figured out how to use that same idea to make real-world objects vanish when shot with microwave energy. More »
BEIJING ? Overseas Tibetan activist groups said security forces fired on Tibetan protesters in southwest China on Monday, killing at least one and injuring others.
Up to several thousand Tibetans in Ganzi prefecture of Sichuan province marched Monday to government offices where security forces opened fire, the Free Tibet group said in an email.
The London-based group said a 49-year-old Tibetan man named Yonten was shot dead and up to 30 others have been shot and wounded in Draggo county.
The claims about Monday's protest could not be independently verified.
A woman who answered the phone at the duty office of the Ganzi public security bureau said she was "not clear" about the situation. "What you should not know, you should not be inquiring about," she said before hanging up.
The unrest comes at a time when tensions are especially high following the self-immolations of at least 16 Buddhist monks, nuns and other Tibetans. Most have chanted for Tibetan freedom and the return of their spiritual leader, the Dalai Lama, who fled to India amid an abortive uprising against Chinese rule in 1959.
Ganzi is a rugged, deeply Buddhist region filled with monasteries and nunneries and has been at the center of dissent for years. It is also among the traditionally Tibetan areas of Sichuan province and other parts of western China that have been closed to outsiders for months amid a massive security presence.
Many Tibetans resent Beijing's heavy-handed rule and large-scale migration of China's ethnic Han majority to the Himalayan region. While China claims Tibet has been under its rule for centuries, many Tibetans say the region was functionally independent for most of that time.
Another group, the International Campaign for Tibet, said three Tibetans were killed in Draggo on Monday and nine injured when police fired into the crowd.
Kate Saunders, the London-based group's spokeswoman, wrote in an email that other Tibetans were beaten by police and injured. It says leaflets had been distributed saying Tibetans should not celebrate the New Year because of the self-immolations and the overall situation in Tibet. The Tibetan New Year falls on Feb. 22 this year.
China is sensitive to protests by Tibetans because they threaten its control over its western region and may inspire protests elsewhere by Chinese with possible grievances.
Codemonkeys exhibiting the kindness of strangers? Why, yes, this is such a tale. When XDA Developers member verygreen came across the pleas of one user obsessed with attaching an external USB keyboard to an eReader, he did what any decent hacker would and created a workable solution. Using a loaned Nook Simple Touch, this self-styled Make-A-Wish Hack was able to patch Barnes & Noble's existing kernel, which already supported USB host mode, and send commands over ADB to enable the connection. It's not a foolproof workaround, though, as only low-power devices will function without additional juice and even so, at a great cost to the greyscale device's battery life. Sure, this may not excite you much, but it's certainly made for one very satisfied forum dweller out there in cyberland. After all, isn't that what haxxors are for?
The race against chronic myeloid leukemia not yet wonPublic release date: 23-Jan-2012 [ | E-mail | Share ]
Contact: Kim Barnhardt kim.barnhardt@cmaj.ca 614-520-7116 x2224 Canadian Medical Association Journal
Although significant progress has been made in treating chronic myeloid leukemia, the disease cannot yet be eliminated in all patients, and that challenge must be addressed, states a commentary in CMAJ (Canadian Medical Association Journal).
Likening the journey to find a cure for chronic myeloid leukemia as a marathon, cancer expert Dr. Jorge Cortes, University of Texas, MD Anderson Cancer Center, Houston, Texas, writes, "The past half century has been an extraordinary run that has us on an excellent pace to not only complete the race to a cure, but to do so in record time."
Developments in treatments have been significant, with a five-year survival rate of 90% today compared with a median survival rate of three to five years in the 1960s.
"Despite this progress, many challenges remain that merit a concerted effort from researchers, health care providers, regulatory authorities, third party payers and the patients themselves," writes Dr. Cortes. "Our goal should be to eliminate the disease in all patients."
The use of the drug imatinib has been a key weapon in the arsenal against the disease, although only 60% of patients have a decent outcome; people can be resistant to the drug or develop resistance. Other second-line drugs work in about 50% of the patients in whom imatinib is not effective, but at least 10%-15% of them will lose their response to the treatment over time.
Dr. Cortes states that doctors need to ensure adherence to treatments, that more research into other therapies is still necessary and that health care professionals must stay focused on the long term.
"Until all patients with chronic myeloid leukemia can have an optimal quality of life while fighting this disease, our marathon is not over," concludes Dr. Cortes.
###
NOTE: Please use the following public links after the embargo lift:
http://www.cmaj.ca/site/press/cmaj111710.pdf
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
The race against chronic myeloid leukemia not yet wonPublic release date: 23-Jan-2012 [ | E-mail | Share ]
Contact: Kim Barnhardt kim.barnhardt@cmaj.ca 614-520-7116 x2224 Canadian Medical Association Journal
Although significant progress has been made in treating chronic myeloid leukemia, the disease cannot yet be eliminated in all patients, and that challenge must be addressed, states a commentary in CMAJ (Canadian Medical Association Journal).
Likening the journey to find a cure for chronic myeloid leukemia as a marathon, cancer expert Dr. Jorge Cortes, University of Texas, MD Anderson Cancer Center, Houston, Texas, writes, "The past half century has been an extraordinary run that has us on an excellent pace to not only complete the race to a cure, but to do so in record time."
Developments in treatments have been significant, with a five-year survival rate of 90% today compared with a median survival rate of three to five years in the 1960s.
"Despite this progress, many challenges remain that merit a concerted effort from researchers, health care providers, regulatory authorities, third party payers and the patients themselves," writes Dr. Cortes. "Our goal should be to eliminate the disease in all patients."
The use of the drug imatinib has been a key weapon in the arsenal against the disease, although only 60% of patients have a decent outcome; people can be resistant to the drug or develop resistance. Other second-line drugs work in about 50% of the patients in whom imatinib is not effective, but at least 10%-15% of them will lose their response to the treatment over time.
Dr. Cortes states that doctors need to ensure adherence to treatments, that more research into other therapies is still necessary and that health care professionals must stay focused on the long term.
"Until all patients with chronic myeloid leukemia can have an optimal quality of life while fighting this disease, our marathon is not over," concludes Dr. Cortes.
###
NOTE: Please use the following public links after the embargo lift:
http://www.cmaj.ca/site/press/cmaj111710.pdf
[ | E-mail | Share ]
?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
![Click here to read Scientists Completely "Cloak" Three-Dimensional Objects for the First Time](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_ujF2b_2nD4OpjEY_KVMdc16M6X-GBTd_w7i0dwwdC8cI-2MWRh0bz7pI2D3YQDcwDjkxGJOlZMBRd7MBKBcHmfJZ59GcyVpSpX8yqqECCVAhZqzcsXC_gz4L78nwc4RPiqsKJXPXqLff7qLQCG-xX1PtzimmD0yKUzu7gCluo=s0-d "Click here to read Scientists Completely "Cloak" Three-Dimensional Objects for the First Time")
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vPDqBGkSS4wKpaKCliKxCkgPAlIropeewtNFp4ljkoJBcMbYhBMDa66y4n_U--CkNxHv3Sp4Y9avKJrz5Y2YQATPMhNLtsc4QaIf2lpCE=s0-d){kind=small}
Public release date: 23-Jan-2012
Share ]